- US-listed companies
- NORTHWEST BIOTHERAPEUTICS INC
- Income statement
NORTHWEST BIOTHERAPEUTICS INCNWBO
Market cap
$364.6M
P/E ratio
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Revenue | 3 | 4 | 4 | 1 | 2 | 1 | 0 | 0 | - | - | - | - | - | 1 |
| Revenue growth (%) | - | - | - | - | - | - | - | |||||||
| Cost of revenue | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | - | - |
| Research & development | 90 | 119 | 163 | 86 | 103 | 60 | 34 | 18 | - | - | - | - | - | 35 |
| Operating margin (%) | - | - | - | - | - | |||||||||
| Operating income | -27 | -44 | -57 | -101 | -126 | -79 | -55 | -41 | - | - | - | - | - | -67 |
| Net income | -33 | -67 | -66 | -136 | -115 | -80 | -73 | -36 | -20 | -530 | 179 | -105 | -63 | -84 |
| Net income margin (%) | - | - | - | - | - | |||||||||
| Earnings per share | -0.35 | - | - | - | - | - | - | - | - | - | - | - | - | -0.07 |
| Diluted EPS | -0.35 | - | - | - | - | - | - | - | - | - | - | - | - | -0.07 |